Your browser doesn't support javascript.
loading
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.
Baker, Jeremy D; Uhrich, Rikki L; Kraemer, Gerald C; Love, Jason E; Kraemer, Brian C.
Affiliation
  • Baker JD; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, United States of America.
  • Uhrich RL; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States of America.
  • Kraemer GC; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States of America.
  • Love JE; Thomas Jefferson High School, Auburn, WA, United States of America.
  • Kraemer BC; Western Washington Pathology, Tacoma, WA, United States of America.
PLoS One ; 16(2): e0245962, 2021.
Article in En | MEDLINE | ID: mdl-33524017
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Protease Inhibitors / Hepatitis C / Hepacivirus / Drug Evaluation, Preclinical / Drug Repositioning / SARS-CoV-2 Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Protease Inhibitors / Hepatitis C / Hepacivirus / Drug Evaluation, Preclinical / Drug Repositioning / SARS-CoV-2 Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States